News

Newsletter title

Department of Biomedicine Newsletter No. 4

We're pleased to announce the release of the fourth edition of our DBM newsletter. We hope you enjoy reading it!
.

/ News, Research

Emerging insights reveal that rare diseases may be more prevalent than previously thought (Recher Lab)

The DBM congratulates Professor Mike Recher and his team, along with Dr. Hiroyuki Yamamoto's group from the National Institute of Infectious Diseases in Tokyo, Japan, on their recent publication in The Journal of Allergy and Clinical…
.

/ News, Research

New vaccine concept against SARS-CoV-2 successfully tested

Researchers at the University of Basel have developed a new approach for a vaccine against COVID-19. This vaccine is based on a modified coronavirus that can enter body cells and trigger an effective immune response but cannot multiply in…
.

/ News, Research

TBVAC-HORIZON kicks off (King Lab and Pinschewer Lab)

The Horizon Europe programme has funded the TBVAC-HORIZON project to improve the understanding of lung immunity to tuberculosis infection and to establish a diversified innovative TB vaccine pipeline targeting mucosal immunity. The King and…
graphical abstract

/ News, Research

New insights in the understanding of a highly aggressive form of childhood leukemia (Schwaller Lab)

New research has shed light on the molecular mechanisms behind a rare and aggressive form of childhood leukemia known as pure red cell leukemia (PEL). The study, published in the journal Blood, was led by Juerg Schwaller and his team at the…